Vor Biopharma (VOR) Interest Expenses (2020 - 2026)
Vor Biopharma (VOR) posted quarterly Interest Expenses of $110000.0 for Q1 2026, down 93.48% year-over-year from $1.7 million in Q1 2025, and little changed quarter-over-quarter from $110000.0 in Q4 2025.
Vor Biopharma (VOR) Interest Expenses (2020 - 2026) Analysis & Trends
Vor Biopharma (VOR) has reported Interest Expenses for 7 consecutive years, with $110000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Expenses fell 93.48% year-over-year to $110000.0; the TTM figure through Mar 2026 stood at $10.5 million (up 56.94% YoY), while the FY2025 annual figure was $232.7 million, up 67.18% from the prior year.
- Interest Expenses steadied at $110000.0 in Q1 2026 per VOR's latest filing, from $110000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $10.2 million in Q2 2025 and bottomed at $36000.0 in Q3 2025.
- Historically, Interest Expenses has averaged $1.6 million across 5 years, with a median of $1.3 million in 2022.
- Annual changes were most pronounced in 2022 — Interest Expenses tumbled 99.65% — and 2025, when it surged 14465.71%.
- Vor Biopharma's Interest Expenses stood at $2.7 million in 2022, then fell by 11.85% to $2.4 million in 2023, then retreated by 29.65% to $1.7 million in 2024, then tumbled by 93.47% to $110000.0 in 2025, then changed by 0.0% to $110000.0 in 2026.
- Business Quant data shows VOR's Interest Expenses at $110000.0 in Q1 2026, $110000.0 in Q4 2025, and $36000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Vor Biopharma | 1.36 Bn | 1.36 Bn | - | 922,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 922,000.00 |
| Jun 30, 2026 | 922,000.00 |
| Mar 31, 2026 | 110,000.00 |
| Mar 31, 2026 | 110,000.00 |
| Dec 31, 2025 | 110,000.00 |
| Dec 31, 2025 | 110,000.00 |
| Sep 30, 2025 | 36,000.00 |
| Sep 30, 2025 | 36,000.00 |
| Jun 30, 2025 | 10.20 Mn |
| Jun 30, 2025 | 10.20 Mn |
| Mar 31, 2025 | 1.69 Mn |
| Mar 31, 2025 | 1.69 Mn |
| Dec 31, 2024 | 1.69 Mn |
| Dec 31, 2024 | 1.69 Mn |
| Sep 30, 2024 | 1.65 Mn |
| Sep 30, 2024 | 1.65 Mn |
| Jun 30, 2024 | 70,000.00 |
| Jun 30, 2024 | 70,000.00 |
| Mar 31, 2024 | 1.64 Mn |
| Mar 31, 2024 | 1.64 Mn |